Child health in the metacrisis

Child health in the metacrisis

Up next

Creative destruction in global health

This episode launches Season 5 of Global Health Matters, which will explore the future of global health. In a time of turbulence, transition and transformation, we need diverse voices to help shape what comes next. In this episode, host <a href='https://can01.safelink ...

  Show more

Trailblazers with Garry: a conversation with Lena Nanushyan

"Trailblazers with Garry" is a new series from Global Health Matters, where host Dr <a href='https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fgarry-aslanyan%2F&data=05%7C02%7Cobadiah.george%40utoronto.ca% ...

  Show more

Recommended Episodes

Introduction to Global Health
The Rx Bricks Podcast

<h2 id="header-9c83a0c4947a4ff482f264ddb56bfda5" class="brick-header brick-header-primary markup-enabled medium-editor-element" role="textbox" data-rxannotationdata="content.text" data-medium-editor-element="true" aria-multiline="true" data-medium-editor-editor-index="1" data-pla ...  Show more

Let's Diagnose Global Health Today | Dr Slim Slama
The afikra Podcast

The CEO of the World Innovation Summit for Health (WISH), Dr Slim Slama, joins us on this episode of The afikra Podcast to give an in-depth look into the complexities and challenges facing global health today, including the rise of non-communicable diseases, the impact of urba ...

  Show more

Youth skills in a rapidly changing world
Our World, Connected

Meet Dr John Mugo and Beria Wawira – two colleagues on a mission to empower millions of young people and parents through the Zizi Afrique Foundation in Kenya. In conversation with host Christine Wilson, they ask: are we preparing young people for success in today’s fast-paced ...

  Show more

#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters

Send a text message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amste ...  Show more